Advanced glycation end products in diabetes, cancer and phytochemical therapy

Begum Dariya1, Ganji Purnachandra Nagaraju2

  • 1Department of Biosciences and Biotechnology, Banasthali University, Banasthali, Rajasthan 304022, India.

Drug Discovery Today
|July 12, 2020
PubMed

Insights

Advanced glycation end products (AGEs) link diabetes and cancer by binding to RAGE. Phytochemicals like genistein and curcumin may block AGE formation and RAGE interaction, offering therapeutic potential.

Area of Science:

  • Biochemistry
  • Molecular Biology
  • Pathophysiology

Background:

  • Irreversible protein and lipid modification by glycation and oxidation generates advanced glycation end products (AGEs).
  • AGEs interact with the receptor for AGE (RAGE), activating signaling pathways like NF-κB and PI3K/Akt.
  • This AGE-RAGE axis is implicated in the pathogenesis of diabetes and various cancers.

Purpose of the Study:

  • To review the molecular mechanisms of AGE-RAGE interaction and associated signaling.
  • To explore the potential of phytochemicals in mitigating AGE formation and RAGE activation.

Main Methods:

  • Literature review focusing on AGE-RAGE axis and phytochemical activity.
  • Analysis of signaling pathways downstream of RAGE activation.
  • Examination of dicarbonyl compound trapping by phytochemicals.

Main Results:

  • The AGE-RAGE interaction triggers key inflammatory and proliferative signaling cascades.
  • Phytochemicals, including genistein and curcumin, can inhibit AGE formation by trapping dicarbonyl precursors.
  • Glyoxalase activity also plays a role in preventing AGEs.

Conclusions:

  • The AGE-RAGE pathway is a critical mediator in diabetes and cancer development.
  • Targeting AGE formation and RAGE signaling with phytochemicals presents a promising therapeutic strategy.

Related Concept Videos

Diabetes: Management and Pharmacotherapy01:15

Diabetes: Management and Pharmacotherapy

The therapy for diabetes aims to alleviate hyperglycemia-related symptoms, prevent acute metabolic decompensation, and reduce chronic end-organ complications. Glycemic control is evaluated through short-term (self-monitoring, continuous glucose monitoring) and long-term (A1c, fructosamine) metrics, enabling near real-time tracking of blood glucose levels and reflecting glycemic control over specific time frames.
Insulin remains the cornerstone of treatment for most patients with type 1 and many...
769
Psychoneuroimmunology: Diabetes and Cancer01:19

Psychoneuroimmunology: Diabetes and Cancer

Chronic stress has been linked to both the onset and progression of serious health conditions, including Type 2 diabetes and cancer. Type 2 diabetes, a widespread chronic illness, is closely associated with obesity and insulin resistance, both of which often worsen under stress. Studies indicate that men experiencing high levels of chronic stress face a 45% higher risk of developing diabetes compared to those with minimal stress. Stress triggers physiological responses that elevate blood...
346
Diabetes: Symptoms, Diagnosis, and Complications01:15

Diabetes: Symptoms, Diagnosis, and Complications

For most patients, experiencing several weeks of polyuria, polydipsia, fatigue, and significant weight loss may indicate the presence of diabetes. Furthermore, adults displaying the phenotypic appearance of type 2 diabetes (particularly those who are obese and not initially insulin-requiring), may have islet cell autoantibodies, suggesting autoimmune-mediated β cell destruction and a diagnosis of latent autoimmune diabetes of adults (LADA). The categorization of glucose homeostasis is...
1.9K
Diabetes Mellitus: Type 2 and Gestational01:22

Diabetes Mellitus: Type 2 and Gestational

Type 2 diabetes, characterized by insulin resistance, arises when the insulin receptors on cells lose responsiveness to insulin, diminishing the cell's capacity to take up glucose, resulting in elevated blood glucose levels. To receive a diagnosis of Type 2 diabetes, a series of blood glucose tests are necessary to assess whether the blood glucose falls within normal parameters. If the result is out of the normal range, a patient may be diagnosed as prediabetic or diabetic, depending on the...
4.1K
Oral Hypoglycemic Agents: Biguanides and Glitazones01:26

Oral Hypoglycemic Agents: Biguanides and Glitazones

Biguanides, particularly metformin (Glucophage), are insulin sensitizers that enhance glucose uptake, thereby reducing insulin resistance. Unlike sulfonylureas, metformin doesn't prompt insulin secretion, which helps to curb hypoglycemia risk. Metformin is beneficial in treating conditions like polycystic ovary syndrome due to its insulin-resistance reduction capability. The drug's primary action involves curtailing hepatic gluconeogenesis, a significant contributor to high blood...
513
Carbohydrate Metabolism01:36

Carbohydrate Metabolism

Carbohydrates are polymers composed of molecules containing atoms of carbon, hydrogen and oxygen. One gram of carbohydrate can provide four kilo-calories of energy, which makes it the most efficient instant energy source.
Starch accounts for approximately 60% of the carbohydrates consumed by humans. Since amylase enzymes cannot function in the stomach's acidic environment, starch can only be digested in the mouth and small intestine. Simple sugars are found naturally in milk and fruits in...
13.4K